6-Chloro-8-methylimidazo[1,2-b]pyridazine

Catalog No.: 
ACGFDJ845
CAS No.: 
17412-22-5
Molecular Formula: 
C7H6ClN3
Molecular Weight: 
167.60
6-Chloro-8-methylimidazo[1,2-b]pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%
250mg95%
500mg95%
1g95%
5g95%
10g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-8-methylimidazo[1,2-b]pyridazine
IUPAC Name6-chloro-8-methylimidazo[1,2-b]pyridazine
MDL No.MFCD32862323
Molecular FormulaC7H6ClN3
Molecular Weight167.60
SMILESCC1=CC(Cl)=NN2C1=NC=C2
InChI KeyFGCJTUFIQAVKHQ-UHFFFAOYSA-N
SynonymImidazo[1,2-b]pyridazine, 6-chloro-8-methyl-;6-chloro-8-methylimidazo[1,2-b]pyridazine
CAS No.17412-22-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACGFDJ845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVHWC297 route compound structure diagram
    ACVHWC297933190-51-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFDJ845 route product structure diagram
    ACGFDJ84517412-22-5In Stock
Inquiry

2. ACGFDJ845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6
  2. Plus
  3. ACVHWC297 route compound structure diagram
    ACVHWC297933190-51-3In Stock
  4. Then
  5. ACGFDJ845 route product structure diagram
    ACGFDJ84517412-22-5In Stock
Inquiry

3. ACGFDJ845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFDJ845 route product structure diagram
    ACGFDJ84517412-22-5In Stock
Inquiry

Comments (0)